LASINTRA-50 TABLET
MRP: 4,800
Packaging: 10X1X4
Pack Type: tablet
Composition:
Lasmiditan 50mg
Indication:
used to treat the symptoms of migraine headaches
Description:
Lasmiditan 50 mg is a centrally acting selective 5-HT1F receptor agonist used for the acute treatment of migraine with or without aura in adults. Unlike traditional triptans, Lasmiditan does not cause vasoconstriction, making it a safer option for patients with cardiovascular risk factors.
It works by targeting serotonin (5-HT) receptors in the brain involved in migraine pathophysiology, helping relieve migraine pain, nausea, photophobia, and phonophobia within a few hours of onset.
Lasmiditan is for acute relief, not for migraine prevention.
Tags:
- Rapid relief from migraine symptoms
- Non-vasoconstrictive (safe for heart patients)
- Effective for migraines with or without aura
- Can be used when other treatments fail
- Fewer cardiovascular risks compared to triptans
- Oral tablet for easy administration
Usage Information
Dosage
Recommended dose: 50 mg taken orally at the onset of migraine symptoms. Maximum dose: One dose per 24 hours. Higher doses (100 mg, 200 mg) may be prescribed if needed under supervision. Do not drive or operate machinery for at least 8 hours after taking Lasmiditan due to potential drowsiness.
Side Effects
Dizziness Fatigue Drowsiness Nausea Paresthesia (tingling) Impaired attention or coordination Avoid alcohol and sedatives. Most side effects are mild and self-limiting.
Contraindications
Known hypersensitivity to Lasmiditan or any component Use of CNS depressants (e.g., benzodiazepines) may increase sedation Not for use in preventive migraine therapy Avoid in patients with severe hepatic impairment Not approved for patients under 18 years of age Not to be taken with other migraine-specific drugs within 24 hours (e.g., triptans or ergotamines)